Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...

A startup looking to develop digital copies of patients in clinical trials—allowing computer models of study participants to be generated ahead of time—has raised $50 million for its machine ...

SAN FRANCISCO--(BUSINESS WIRE)--After securing over $130M in funding and achieving multiple regulatory successes, Unlearn today announced changes to its executive leadership to support the commercial ...

Unlearn.AI has moved its headquarters into larger San Francisco offices in anticipation of employee growth. The locally based artificial intelligence startup relocated last month after it signed a ...